First Time Loading...

Sakura Rubber Co Ltd
TSE:5189

Watchlist Manager
Sakura Rubber Co Ltd Logo
Sakura Rubber Co Ltd
TSE:5189
Watchlist
Price: 2 401 JPY -11.73% Market Closed
Updated: Apr 29, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

14.3B
+4%
Assets
Growth Rates:
1 Year
+3%
3 Years
+2%
5 Years
+8%
7 Years
+19%
10 Years
+24%
6.2B
+6%
Liabilities
Growth Rates:
1 Year
-2%
3 Years
-9%
5 Years
-7%
7 Years
-1%
10 Years
-13%
8B
+2%
Equity
Growth Rates:
1 Year
+8%
3 Years
+12%
5 Years
+25%
7 Years
+40%
10 Years
+85%

Balance Sheet Decomposition
Sakura Rubber Co Ltd

14.3B
Assets
6.2B
Liabilities
14.3B
Assets
6.2B
Liabilities
Current Assets 9.9B
Cash & Short-Term Investments 2.7B
Receivables 3.3B
Other Current Assets 3.9B
Non-Current Assets 4.3B
Long-Term Investments 405m
PP&E 3.4B
Intangibles 21.4m
Other Non-Current Assets 499m
Current Liabilities 3.5B
Accounts Payable 1.3B
Accrued Liabilities 90.5m
Short-Term Debt 810m
Other Current Liabilities 1.3B
Non-Current Liabilities 2.8B
Long-Term Debt 1.5B
Other Non-Current Liabilities 1.3B

Balance Sheet
Sakura Rubber Co Ltd

Rotate your device to view
Balance Sheet
Currency: JPY
Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
2 343
2 146
2 284
2 192
2 218
2 104
2 494
3 344
3 356
3 023
Cash Equivalents
2 343
2 146
2 284
2 192
2 218
2 104
2 494
3 344
3 356
3 023
Total Receivables
4 910
3 845
4 118
4 203
4 370
4 818
5 663
3 607
3 616
6 065
Accounts Receivables
4 910
3 845
4 118
4 203
4 370
4 818
5 663
3 464
3 607
6 065
Other Receivables
0
0
0
0
0
0
0
143
9
0
Inventory
2 601
2 086
2 260
2 304
2 313
2 469
2 859
2 674
2 470
2 713
Other Current Assets
199
173
159
162
55
87
73
78
86
124
Total Current Assets
10 053
8 251
8 821
8 862
8 957
9 479
11 090
9 704
9 527
11 925
PP&E Net
3 324
3 479
3 560
3 605
3 594
3 634
3 960
4 231
3 960
3 499
PP&E Gross
3 324
3 479
3 560
3 605
3 594
3 634
3 960
4 231
3 960
3 499
Accumulated Depreciation
7 214
7 343
7 495
7 668
7 860
8 072
8 229
8 429
8 484
8 709
Intangible Assets
17
16
17
15
13
12
12
15
26
23
Goodwill
10
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
227
269
237
284
301
252
233
288
274
297
Other Long-Term Assets
222
186
258
259
392
467
563
537
589
580
Other Assets
10
0
0
0
0
0
0
0
0
0
Total Assets
13 853
N/A
12 206
-12%
12 892
+6%
13 026
+1%
13 258
+2%
13 844
+4%
15 858
+15%
14 775
-7%
14 375
-3%
16 324
+14%
Liabilities
Accounts Payable
2 925
1 910
1 774
1 416
1 518
1 806
2 874
1 921
1 704
3 396
Accrued Liabilities
319
306
314
331
324
319
356
248
155
289
Short-Term Debt
1 340
605
1 495
1 320
1 230
1 190
1 000
1 150
940
820
Current Portion of Long-Term Debt
824
716
936
785
952
762
615
645
807
811
Other Current Liabilities
1 325
1 057
823
1 009
779
774
1 052
642
544
675
Total Current Liabilities
6 734
4 594
5 342
4 860
4 804
4 851
5 897
4 606
4 150
5 991
Long-Term Debt
1 607
1 660
1 179
1 183
999
1 179
1 539
1 577
1 704
1 473
Deferred Income Tax
7
10
13
18
0
21
17
20
11
12
Other Liabilities
1 039
963
1 001
1 045
1 081
1 181
1 185
1 008
1 065
1 084
Total Liabilities
9 387
N/A
7 227
-23%
7 535
+4%
7 107
-6%
6 884
-3%
7 232
+5%
8 638
+19%
7 212
-17%
6 931
-4%
8 560
+24%
Equity
Common Stock
506
506
506
506
506
506
506
506
506
506
Retained Earnings
3 776
4 248
4 801
5 318
5 836
6 215
6 833
7 001
6 858
7 148
Additional Paid In Capital
285
285
285
285
285
285
285
285
285
285
Unrealized Security Profit/Loss
48
80
0
88
98
62
54
92
83
99
Treasury Stock
47
65
0
85
141
173
173
173
174
174
Other Equity
103
75
207
193
210
283
286
148
114
101
Total Equity
4 466
N/A
4 979
+11%
5 357
+8%
5 918
+10%
6 374
+8%
6 613
+4%
7 220
+9%
7 564
+5%
7 445
-2%
7 763
+4%
Total Liabilities & Equity
13 853
N/A
12 206
-12%
12 892
+6%
13 026
+1%
13 258
+2%
13 844
+4%
15 858
+15%
14 775
-7%
14 375
-3%
16 324
+14%
Shares Outstanding
Common Shares Outstanding
1
1
1
1
1
1
1
2
2
2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.